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Cancer cell migration is an early event in metastasis,
the main cause of breast cancer-related deaths. Cho-
lesterol-enriched membrane domains called lipid
rafts influence the function of many molecules, in-
cluding the raft-associated protein CD44. We describe
a novel mechanism whereby rafts regulate interac-
tions between CD44 and its binding partner ezrin in
migrating breast cancer cells. Specifically, in nonmi-
grating cells, CD44 and ezrin localized to differentmem-
branous compartments: CD44 predominantly in rafts,
and ezrin in nonraft compartments. After the induction
of migration (either nonspecific or CD44-driven), CD44
affiliation with lipid rafts was decreased. This was ac-
companied by increased coprecipitation of CD44 and
active (threonine-phosphorylated) ezrin-radixin-moe-
sin (ERM) proteins in nonraft compartments and in-
creased colocalization of CD44with the nonraft protein,
transferrin receptor. Pharmacological raft disruption
using methyl--cyclodextrin also increased CD44-ezrin
coprecipitation and colocalization, further suggesting that
CD44 interacts with ezrin outside rafts during migration.
Conversely, promoting CD44 retention inside lipid rafts
by pharmacological inhibition of depalmitoylation virtu-
ally abolishedCD44-ezrin interactions.However, transient
single or double knockdown of flotillin-1 or caveolin-1
was not sufficient to increase cell migration over a short
time course, suggesting complex crosstalk mechanisms.
We propose a newmodel for CD44-dependent breast can-
cer cell migration, where CD44 must relocalize outside
lipid rafts to drive cell migration. This could have implica-
tions for rafts as pharmacological targets to down-regulate
2172cancer cell migration. (Am J Pathol 2012, 181:2172–2187;
http://dx.doi.org/10.1016/j.ajpath.2012.08.025)
The membrane protein CD44 is a multifaceted molecule
involved in many different cellular processes, including
organ development, neuronal axon guidance, immune
functions, hematopoiesis, and migration.1–4 It acts as a
receptor for the extracellular matrix component hyal-
uronic acid (HA)5,6 and for the secreted extracellular
protein osteopontin.7 CD44 is an important mediator of
cellular adhesion and migration due to its active influence
on the organization of the actin cytoskeleton. This occurs
through direct interactions between CD44 and different
actin-binding partners, of which the most common are
proteins belonging to the ezrin-moesin-radixin (ERM)
family. The ERM proteins form a bridge between CD44
and the actin cytoskeleton, mediating cell morphology
changes that are important for cell migration. Ezrin inter-
acts with CD44 and F-actin, respectively, through its con-
served N-terminal band four-point-one, ezrin, radixin,
moesin domain and C-terminal ERM Association Domain
Supported by Cancer Research Ireland (CRI05HOP/AMH), the Irish Re-
search Council for Science, Engineering & Technology (EMBARK 2005/
SD), Health Research Board of Ireland (HRA/2009/49 to A.M.H.), Breast
Cancer Ireland, EU-funded Network of Excellence ENFIN (LSHG-CT-
2005-518254), and the UK Medical Research Council (L.D.H.). The con-
focal microscope and ultracentrifuge were funded through the National
Biophotonics and Imaging Platform, Ireland, and funded by the Irish
Government’s Programme for Research in Third Level Institutions, Cycle
4, Ireland’s EU Structural Funds Programmes 2007–2013.
Accepted for publication August 13, 2012.
S.D. and I.S.B. contributed equally to this work.
CME Disclosure: The authors of this article and the planning committee
members and staff have no financial relationships with commercial inter-
est to disclose.
Supplemental material for this article can be found at http://ajp.
amjpathol.org or at http://dx.doi.org/10.1016/j.ajpath.2012.08.025.
Address reprint requests to Ann M. Hopkins, Ph.D., Department of
Surgery, Royal College of Surgeons in Ireland, RCSI Education and Re-
search Centre, Beaumont Hospital, Dublin 9, Ireland. E-mail:
annhopkins@rcsi.ie.
Lipid Rafts and Breast Cancer Migration 2173
AJP December 2012, Vol. 181, No. 6domain. In the inactive configuration of ezrin, both do-
mains interact with each other and block the binding sites
for CD44 and F-actin. Ezrin activation is mediated by
phosphorylation-induced conformational changes,8 with
phosphorylation on threonine-567 being necessary for
binding to the F-actin cytoskeleton.9
Phosphorylation of CD44 has also been shown to be
important for its activation, particularly on serine residues
in the C-terminal domain.8,10 CD44 has been described
to be enriched in cholesterol- and sphingomyelin-en-
riched membrane microdomains termed lipid rafts.11
Much evidence has suggested the involvement of lipid
rafts in regulating different cellular events, including mi-
gration.12 Because some of these cellular events are
frequently altered in cancer, it has been hypothesized
that lipid rafts play a crucial role in regulating cancer
progression.13 However, although alterations in CD44 ex-
pression have been associated with many cancers,14
how lipid rafts influence the subcellular localization (and
thus migratory functions) of CD44 and its contribution
toward cancer progression is not well understood.
Whether or not CD44 and its binding partners local-
ize to lipid rafts may in fact regulate several signaling
cascades. CD44 is usually directed toward lipid rafts
via posttranslational lipid modifications called acyla-
tion reactions, the most common of which is palmitoyl-
ation. Due to its dynamic and reversible nature, palmi-
toylation can have important functions in dictating
protein fate such as protein trafficking, lateral segre-
gation, and cellular localization. Palmitoylation plays
an important role in CD44-HA turnover, with palmitoy-
lated CD44 promoting CD44-HA endocytosis. Accord-
ingly, lipid rafts have been described to play an impor-
tant role in cellular endocytosis.15
Ezrin localization to lipid rafts is controversial16 and the
mechanisms regulating its affiliation with lipid rafts incom-
pletely understood. Ezrin interactions with phosphatidyl-
inositol 4,5-biphosphate (PIP2) may be important for its
activation, causing the four-point-one and C-terminal
ERM domains to open17 and permitting ezrin localization
at the plasma membrane.18 Because PIP2 has been de-
scribed to be enriched in lipid rafts,19 it is possible that
ezrin localizes to lipid rafts through an interaction with
PIP2.
In this paper, we set out to investigate the role of lipid
rafts in regulating CD44-dependent breast cancer cell
migration. Our initial findings revealed that CD44 and
ezrin localized to different membrane fractions in nonmi-
grating cells, biochemically characterized as lipid raft
and nonraft domains, respectively. In response to migra-
tory stimuli (either random or CD44-specific), the propor-
tion of raft-affiliated CD44 decreased whereas that of
ezrin did not change. Moreover, under migrating com-
pared to nonmigrating conditions, immunofluorescence
confocal microscopy revealed increased colocalization
of CD44 with the nonraft marker transferrin receptor. Al-
together, we present novel evidence that physical inter-
actions between CD44 and ezrin occur in nonraft frac-
tions of migrating cells. In support of our observations,
pharmacological disruption of lipid rafts increased CD44-
ezrin coprecipitation, whereas enhanced retention ofCD44 within rafts abolished CD44-ezrin coprecipitation.
Surprisingly, flotillin-1 or caveolin-1 transient knockdown
alone did not affect cell migration in these cells, suggest-
ing compensatory mechanisms that make up for the pre-
sumed loss of one or other raft compartment. In support
of this assumption, coincident knockdown of flotillin-1
and caveolin-1 significantly impaired cell migration.
Nonetheless, our data are consistent with a novel regu-
latory mechanism in which CD44 translocates outside
lipid rafts to bind ERM binding partners such as ezrin and
drive cell migration. Future exploration of the precise
mechanisms regulating this translocation may reveal fu-
ture targets for interfering with breast cancer cell migra-
tion during the early stages of metastasis.
Materials and Methods
Antibodies and Reagents
CD44 antibodies were purchased from Santa Cruz Bio-
technology (immunoprecipitations and immunofluores-
cence; Santa Cruz Biotechnology, Heidelberg, Ger-
many), Abcam and R&D Systems (Western blotting;
Abcam, Cambridge, UK, and R&D Systems, Abingdon,
UK); ezrin from BD Biosciences (Oxford, UK); phospho-
threonine-ERM from Cell Signaling Technology (Danvers,
MA), flotillin-1 from BD Biosciences, actin from Sigma-
Aldrich (Arklow, Ireland), caveolin-1 from Cell Signaling
Technology, radixin and moesin from GeneTex/Source
Biosciences (Irvine, CA), transferrin receptor primary and
Alexa-Fluor secondary antibodies both from Invitrogen
(Bio-Sciences, Dun Laoghaire, Ireland). Triton X-100
(10%) was purchased from Roche (Dublin, Ireland),
protein G-sepharose 4B from GE Healthcare (Little
Chalfont, UK).
Cell Culture
MDA-MB-231 cells were obtained from the ATCC (Ma-
nassas, VA) and cultured in Dulbecco’s modified Eagle’s
medium, 10% fetal bovine serum, 2 mmol/L L-glutamine,
100 U/mL penicillin, and 100 g/mL streptomycin. MDA-
MB-231 cells stably knocked-down for caveolin-1 via a
vector containing short-hairpin RNA against caveolin-1
and carrying a resistance cassette for blasticidin (Invitro-
gen)20 were cultured similarly but with the addition of 5
ng/L blasticidin. For some experiments, small-interfer-
ing RNA (siRNA) against flotillin-1 or caveolin-1 was used
to transiently knock down gene expression for 72 hours
before performing migration assays or immunofluores-
cence analysis. In brief, cells were grown at low density
for up to 24 hours on 24-well plates or 13-mm coverslips
and transfected with 25 nmol/L siRNA against flotillin-1 or
caveolin-1 (Dharmafect SmartPools; Dharmacon, Lafay-
ette, CO) or a universal negative control siRNA (Dharma-
fect) using Dharmafect-1 reagent as per the manufactur-
er’s instructions (Dharmacon).
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Methyl--cyclodextrin (MCD, 10 mmol/L; Sigma-Aldrich)
was used to disrupt lipid raft physiology by cholesterol
depletion as already described.21–23 MCD was prepared
in serum-free medium and added to confluent 10-cm
dishes of cells for 30 minutes before wounding with a sterile
pipette tip attached to a vacuum. To convert a proportion of
cells into spreading and migrating cells, monolayers were
extensively wounded by making nine horizontal and nine
vertical scratches per dish using a sterile pipette tip at-
tached to suction. Depalmitoylation inhibitors (DPI) methyl
arachidonyl fluorophosphonate (5 mol/L) and palmityl trif-
luoromethyl ketone (20 mol/L) were obtained from Cay-
man Chemicals (Ann Arbor, MI) and incubated with cells for
30 minutes before wounding. All treated cells were washed
once and allowed to migrate in serum-free medium for the
indicated times. Confluent cells were wounded and treated
for 30 minutes with 5 mg/mL HA where indicated.
Scratch-Wound Migration Assays
Cells were grown to confluence in 24-well plates and
scratch wounded once using a sterile pipette tip attached
to a vacuum. Cells were then washed once and incu-
bated in the relevant treatments in serum-free medium.
Wounds were photographed at specific time points on a
phase contrast microscope linked to a charge-coupled
device camera (Olympus, Tokyo, Japan), and the wound
size at a single reference point measured over time using
Cell B software (Olympus).
Immunofluorescence Microscopy
Cells were grown to confluence on sterile coverslips,
treated as indicated, and then fixed in 3.7% paraformal-
dehyde (pH 7.4) for 10 minutes at room temperature, in
ice-cold ethanol or 80% methanol/20% acetone for 20
minutes at 20°C. The primary antibody and secondary
antibodies (diluted in 5% normal goat serum) were incu-
bated for 1 hour at room temperature. Nuclei were counter-
stained with DAPI for 10 minutes at room temperature. Each
step was followed by three washes in phosphate-buffered
saline (PBS). Coverslips were mounted in PBS:glycerol:p-
phenylenediamine hydrochloride (1:1:0.01 v/v/v) and visu-
alized on a Zeiss LSM 510-meta or 710-meta confocal mi-
croscope using 63 oil immersion lenses (Carl Zeiss,
Oberkochen, Germany).
Protein Immunoprecipitations
Cells were washed in cold PBS, lysed, and scraped in
Relax buffer (100 mmol/L KCl, 3 mmol/L NaCl, 3.5 mmol/L
MgCl2, 10 mmol/L HEPES) containing 1% Triton X-100
and protease and phosphatase inhibitor cocktails (Sig-
ma-Aldrich). Lysates were homogenized with a Dounce
tissue homogenizer (Sigma-Aldrich) 20 times and centri-
fuged at 1500  g at 4°C for 5 minutes. Equivalent
amounts of total protein per treatment condition (eg, mi-
grating versus nonmigrating cell lysates) were used in
matched immunoprecipitation experiments. After a pre-clear step with protein G–sepharose, 3 g of mouse
anti-human CD44 antibody (or an equivalent concentra-
tion of control mouse IgG) was added to each sample
and rotated overnight at 4°C. Immunocomplexes were
collected by rotation with 50 L of protein G–sepharose
for 3 hours at 4°C. Immunocomplexes were washed three
times with lysis buffer, resuspended in 2 Laemmli re-
ducing sample buffer, boiled, and then analyzed by SDS-
PAGE and Western blotting.
Lipid Raft Isolation
Two confluent 10-cm dishes per condition were treated
as described. Hanks balanced salt solution (HBSS) con-
taining calcium, magnesium, and 10 mmol/L HEPES (Sig-
ma-Aldrich) was used to wash cells before scraping them
into 400 L/dish lysis buffer (HBSS, 1% Triton-X100, pro-
tease, and phosphatase inhibitors). Lysates were homog-
enized with a tissue homogenizer 20 and triturated 20
through a 26-gauge needle. At 4°C, lysates were mixed
1:1 with a 90% (w/v) sucrose solution (in HBSS) and
loaded at the bottom of a micro-ultracentrifuge tube. This
was then overlain sequentially with solutions of 30%,
20%, and 5% sucrose (w/v) and ultracentrifuged in an
RP55S rotor at 281,591  g for 19 hours at 4°C in a
Sorvall RC M120EX micro-ultracentrifuge (Kendro Labo-
ratory Products, Asheville, NC). Starting from the top of
the tube (fractions of lowest sucrose density), gradients
were fractionated manually at 4°C into six equal-volume
fractions. For some experiments, continuous sucrose
gradients were prepared from 200-cm dishes of conflu-
ent cells in larger (12-mL) tubes essentially as de-
scribed.24,25 Briefly, cell lysates were prepared in 2.5 mL
of HBSS containing 1% Triton X-100 and a protease in-
hibitor cocktail. At 4°C, 2 mL of lysate was mixed with 2
mL of 60% sucrose and placed at the bottom of an
ultracentrifuge tube. A 200-L “cushion” of 30% sucrose
was manually layered on top, whereupon a continuous
30% to 5% gradient was poured using an Auto Densi-
Flow density gradient fractionator (Labconco, Kansas
City, MO). Gradients were ultracentrifuged at 260,343 
g/19 hours at 4°C in a Beckman Optima L-100K ultracen-
trifuge (Sw41 Ti rotor) and fractionated manually into
12 1-mL fractions. In each case, a peak of alkaline
phosphatase activity and enriched flotillin-1 expression
was used to identify lipid raft fractions. Because both
peaked at 20% to 26% sucrose, irrespective of the
gradient preparation, the small- and large-gradient prep-
arations were highly comparable even though fraction
numbers did not directly correlate. For clarity in Western
blot results, sucrose densities of gradient fractions have
been presented instead of fraction numbers; and frac-
tions with peak alkaline phosphatase activity have been
highlighted with circles.
SDS-PAGE and Western Blot Analysis
Because protein concentrations were nonuniform across
gradient fractions, 5 g of protein per lane (unless oth-
erwise indicated) were separated on fixed-percentage
acrylamide gels at 40-mA constant current. To control for
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duce artifacts not present under equivalent volume load-
ing conditions, electrophoresis of equivalent fraction vol-
umes was also performed in representative blots and
confirmed to have a similar outcome (see Supplemental
Figure S1 at http://ajp.amjpathol.org). Proteins were then
transferred to nitrocellulose membranes at a constant
voltage of 100 V for 1 hour and blocked in 5% nonfat dry
milk Tris-buffered saline (TBS)–0.1% Tween-20 for 1 hour
at room temperature. Primary (as indicated) and second-
ary (mouse-, rabbit-, or rat–horseradish peroxidase con-
jugated; Sigma-Aldrich) antibodies were prepared in 5%
nonfat dry milk in TBS containing 0.1% Tween-20 (TBS-
T). Primary antibodies were incubated overnight at 4°C,
and secondary antibodies for 1 hour at room tempera-
ture. Each step was followed by 3 10-minute washes in
TBS-T. Luminescent signals were developed onto Kodak
film (Rochester, NY) after incubation with Western Light-
ning enhanced chemiluminescent reagent (Perkin Elmer,
Waltham, MA).
Image Analysis
Densitometric analysis of Western blot films was per-
formed using Image J software (NIH, Bethesda, MD).
Pixel colocalization of different color channels in confocal
images was analyzed by Image J software using the
plugins “ColocalizeRGB” and “Area calculator.”
Migration Matrix and Pathway Reconstruction
Immunoprecipitation changes observed within migrating
cells relative to nonmigrating cells were used to infer the
signaling network using logical reasoning.26 For exam-
ple, movement of CD44 from lipid raft to nonraft regions
was presumed if a decrease of CD44 in raft fractions
accompanied by an increase of CD44 in nonraft fractions
was observed. Other network paths were constructed in
the same manner with the additional model constraint
and assumption that CD44 only binds to ezrin in its phos-
phorylated state.8 In all cases, there was an explicit as-
sumption that the total amount of CD44, ezrin, and phos-
pho-ERM remained constant within cells over the time
course of individual experiments (confirmed in Supple-
mental Figure S2 at http://ajp.amjpathol.org).
Statistical Analysis
Data were expressed as mean  SEM. Different condi-
tions were compared using unpaired Student’s t-tests
and nonparametric tests. Linear regression analysis in
GraphPad Prism v5 (GraphPad Software, La Jolla, CA)
was used to test statistical differences between the
slopes of scratch wound assays under different treatment
conditions.Results
CD44 and Ezrin Interact at the Migrating Edge in
MDA-MB-231 Cells
Although the involvement of CD44 in breast cancer mi-
gration has been described in many settings, the regu-
latory mechanisms are incompletely understood and of-
ten conflicting. A likely mechanism is that CD44 interacts
with the actin cytoskeleton through ezrin, a member of the
ERM family.27 We used scratch wounding as a tool to
induce migration in MDA-MB-231 breast cancer cells to
study the role of lipid rafts in regulating CD44 and ezrin
interactions. Monolayers of cells were extensively
wounded by making nine horizontal and nine vertical
scratches per 10-cm dish. The total number of migrating
cells per experiment was estimated by surface area cal-
culations to be less than 10%. Because the mechanical
stress applied by scratch wounding directly stimulates
migration three to five cell diameters back from the
wound edge,28 the depth covered by three to five cells
along each side of each wound was used to calculate the
estimated total migrating surface. However, it is well
known that migrating cells secrete factors that can affect
signaling even in cells distal to those that are directly
migrating.29 Because CD44-ezrin interactions are report-
edly rapid and transient,8 MDA-MB-231 cells were al-
lowed to migrate for 30 minutes in serum-free medium
following scratch wounding. CD44 immunoprecipitate
complexes were separated by SDS-PAGE and analyzed
by immunoblotting for the presence of ezrin and CD44.
Figure 1A shows that CD44 recovery was marginally in-
creased in migrating cells compared to nonmigrating
cells. However, a substantial increase in ezrin recovery
was observed in CD44 immunoprecipitates of migrating
cells compared to nonmigrating controls, even though
CD44 and actin levels in the input lysates were confirmed
to be similar between treatment conditions. Furthermore,
expression levels of CD44 and ezrin were observed to be
stable over a migration time course from 30 minutes to 4
hours (see Supplemental Figure S2 at http://ajp.
amjpathol.org).
To interact with CD44 and the cytoskeleton, ezrin must
undergo posttranslational conformational changes in-
duced by phosphorylation on threonine-567. We used an
antibody that recognizes the phosphorylation of threo-
nine-567 on ezrin and also the corresponding phosphor-
ylation sites on moesin and radixin, related proteins be-
longing to the ERM family. Like ezrin, radixin and moesin
are also highly expressed in MDA-MB-231 cells and ex-
hibit stable levels over a migration time course (see Sup-
plemental Figure S2 at http://ajp.amjpathol.org). As shown
in Figure 1A, threonine-phosphorylated levels of the ERM
proteins (p-ERM) were slightly increased in migrating
cells compared to nonmigrating controls, but with little
overall change in the ratio of p-ERM to total ezrin under
migrating versus nonmigrating conditions. Neither CD44
nor ezrin were detected in lysates immunoprecipitated
with a nonspecific control IgG antibody.
Colocalization of CD44 and ezrin under migrating and
nonmigrating conditions was also examined by confocal
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AJP December 2012, Vol. 181, No. 6Figure 1. CD44 and ezrin interaction during breast cancer cell migration. A: CD44 was immunoprecipitated (IP) from equal amounts of total protein extracted
from migrating (M) and nonmigrating (NM) MDA-MB-231 cells (left panel). Increased binding between CD44 and ezrin was observed in migrating conditions,
but no changes in p-threonine-ERM (p-ERM) binding to CD44 were observed (middle panel) (error bars refer to the SEM of three independent experiments with
unpaired two-tailed t-tests used for statistical analysis). Blots from input lysates (right panel) confirm similar expression levels of CD44, p-ERM, ezrin, and actin
in both treatment conditions. Immunofluorescence analysis of CD44 and ezrin (B, green and red, respectively) or CD44 and p-ERM (C, green and red, respectively)
colocalization (yellow, merge) in nonmigrating (NM) and migrating (M) MDA-MB-231 cells. A significant increase in CD44 and ezrin colocalization was observed
in migrating compared to nonmigrating cells (B) (right panel, *P 0.0108, unpaired two-tailed t-test; error bars represent SEM of two independent experiments),
especially at the leading edge of migrating cells (B, enlargement). C, right panels: A nonsignificant increase of CD44 and p-ERM colocalization was also
observed (white bars). A decrease of total CD44 expression was observed over time (grey bars). Conversely, increased expression and localization of p-ERM in
membrane ruffles at the migrating edge was seen over time in cell migration (C, arrows and enlargement) together with a total increase in p-ERM expression
(C, far right panel, at 30 minutes and at 120 minutes black bars). Error bars refer to the SEM of duplicate experiments.
Error ba
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ing cells, the merged image of CD44 and ezrin demon-
strated significantly increased colocalization, particularly
at the migrating edge (Figure 1B) (differences in pixel
overlap, P 0.05). This suggested that changes in CD44
and ezrin localization within specific cellular regions ac-
companied cell migration. Localization of p-ERM relative
to CD44 was also analyzed by confocal microscopy (Fig-
ure 1C). p-ERM specifically localized to membrane ruf-
fles, as already described,16,30 and was highly polarized
at the leading edge of migrating cells. p-ERM was the
only protein examined that we observed to directly local-
ize in filopodia-like structures at the edge of migrating
cells (Figure 1C). At 30 minutes after induction of migra-
tion, CD44 and p-ERM localization was strongly identified
anterior to such filipodia-like structures (Figure 1C). How-
ever no significant alteration in CD44–p-ERM colocaliza-
tion by ImageJ analysis was detected (Figure 1C). Inter-
estingly, CD44 expression in single planes measured
appeared to decrease, whereas that of p-ERM increased
over time (Figure 1C).
CD44 and Ezrin Stably Interact in Non-Lipid Raft
Regions of Migrating Cells
With evidence that CD44 and ezrin colocalize at the
Figure 2. CD44 and ezrin localization to lipid rafts during breast cancer cell m
cells via isopycnic sucrose density gradient fractionation, and successive fra
concentration, or sucrose density. OD, optical density. B: Equivalent protein
by Western blotting for the expression of CD44, flotillin-1 (Fl-1), ezrin, and
was significantly higher (*P  0.036, unpaired two-tailed t-test) in nonmigra
experiments). C: Equal amounts of total cellular protein from lipid raft an
immunoprecipitated for CD44 and probed for CD44, ezrin, and p-threonine-
raft and nonraft fractions, Western blots of two different exposure times are g
times for nonraft fractions (32% sucrose). Blots from input lysates (righ
compared to nonraft fractions together with ezrin enrichment in nonraft fract
decreased in migrating cells compared to nonmigrating cells, and CD44-ezrin
cells. D: MDA-MB-231 cells were transfected with siRNA against the princip
Migrating versus nonmigrating cells were subsequently analyzed by immuno
panel) or radixin (right panel), which was quantitated with Image J softwar
moesin while significantly increasing the colocalization of CD44 and radixin.
unpaired two-tailed t-test).plasma membrane of migrating MDA-MB-231 cells, wenext investigated whether they localized to the same bio-
chemical compartments within membranes. Because
CD44 has been described to localize to lipid raft do-
mains, we first investigated the distribution of CD44 and
ezrin relative to lipid raft membrane compartments. Lipid
rafts were isolated from migrating or nonmigrating MDA-
MB-231 cells using nondetergent (data not shown) or
detergent extraction methods in combination with isopy-
cnic sucrose density gradient fractionation. Both meth-
ods yielded similar results. Gradient fractions were ana-
lyzed for enzyme activity of the lipid raft marker alkaline
phosphatase,31 protein concentration, and sucrose den-
sity, as shown in Figure 2A. Top fractions from both small-
and large-gradient preparations were characterized by
low alkaline phosphatase activity, a sucrose density of
20%, and negligible protein content (Figure 2A). The
exceptionally low protein content of these fractions
mostly precluded their inclusion in SDS-PAGE gels. Con-
versely, middle fractions exhibited high alkaline phos-
phatase activity, a sucrose density of 20% to 25%, a low
but measurable protein concentration, and high expres-
sion of the lipid raft marker protein flotillin-1 (Figure 2, A
and B). Taken together, this was consistent with the en-
richment of lipid rafts in these fractions. By contrast, the
bulk of total cellular protein content was enriched in flo-
tillin-low fractions at the bottom of sucrose gradients (su-
. A: Lipid rafts were isolated from migrating and nonmigrating MDA-MB-231
alyzed for activity of the raft marker enzyme alkaline phosphatase, protein
trations from gradient fractions were separated by SDS-PAGE and analyzed
ft panel). The amount of CD44 present in lipid raft versus nonraft fractions
pared to migrating cells (right panel) (error bar refers to SEM of triplicate
ipid raft fractions of migrating and nonmigrating MDA-MB-231 cells were
e replicate) (left panel). Due to strong differences in CD44 levels between
ort exposure times for lipid raft fractions (26% sucrose) and longer exposure
; same exposure time) confirmed much higher expression of CD44 in raft
spective of cell migratory status. CD44 recovery from lipid raft fractions was
ipitation was observed predominantly in non-lipid raft fractions of migrating
ural components of different lipid raft populations, flotillin-1, or caveolin-1.
cence confocal microscopy for CD44 colocalization with either moesin (left
in-1 knockdown (KD) significantly decreased the colocalization of CD44 and
rs refer to SEM of representative triplicate images. (*P 0.0247, **P 0.0027,igration
ctions an
concen
actin (le
ting com
d non-l
ERM (on
iven: sh
t panel
ions, irre
coprec
al struct
fluores
e. Flotillcrose density 30%). CD44 was observed to localize
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AJP December 2012, Vol. 181, No. 6mainly in flotillin-enriched lipid raft fractions (Figure 2B),
although it was not exclusively restricted to raft fractions.
By contrast, ezrin was detected throughout flotillin-low
fractions in a pattern similar to that of the nonraft protein
actin (Figure 2B). Interestingly, the relative recovery of
CD44 in flotillin-low (nonraft) fractions was increased after
the induction of migration. This was further supported by
a significant increase in CD44 colocalization with trans-
ferrin receptor, a known marker for nonraft domains, at
the leading edge of migrating cells (see Supplemental
Figure S3 at http://ajp.amjpathol.org). Quantification of
the relative levels of CD44 in raft fractions (normalized to
flotillin-1) versus nonraft fractions (normalized to ezrin)
from multiple experiments confirmed a significant de-
crease in the quantity of raft-affiliated CD44 (Figure 2B)
(P  0.05). Similar results were also obtained using the
invasive breast cancer cell line Hs578T (see Supplemen-
tal Figure S4 at http://ajp.amjpathol.org).
We next used a co-immunoprecipitation approach to
examine whether CD44-ezrin interactions took place in-
side or outside of lipid raft domains. Equal concentrations
of total cellular protein from lipid raft and nonraft fractions
of migrating or nonmigrating cells were immunoprecipi-
tated with CD44 and analyzed for the presence of ezrin
and p-ERM (Figure 2C). As expected, CD44 was highly
enriched in lipid raft fractions of both migrating and non-
migrating cells. However, CD44 recovery from lipid rafts
in migrating cells was less than that in nonmigrating cells,
in conjunction with the appearance of a small pool of
CD44 in immunoprecipitates from nonraft fractions of mi-
grating cells. Interestingly, ezrin was significantly en-
riched in CD44 immunoprecipitates recovered from non-
raft fractions of migrating cells (Figure 2C). The absence
of detectable ezrin bands in the other immunoprecipitate
lanes does not exclude CD44-ezrin coprecipitation, but
rather illustrates that such interactions take place at ex-
ceptionally low levels relative to the coprecipitation of
CD44-ezrin in nonraft fractions from migrating cells. In-
terestingly, this suggests that even a very small pool of
CD44 in nonraft fractions of migrating cells is sufficient to
account for the bulk of interactions with ezrin. More im-
portantly, it also suggests that CD44 and ezrin interact
outside lipid rafts during cell migration. Accordingly,
p-ERM showed a dramatic enrichment in nonraft fractions
from CD44 immunoprecipitates of migrating cells (Figure
2C). These results further supported the hypothesis that
interactions between CD44 and ERM proteins such as
ezrin occur outside lipid rafts in migrating cells. However,
because radixin and moesin are also expressed in MDA-
MB-231 cells (see Supplemental Figure S2 at http://
ajp.amjpathol.org), it is likely that the p-ERM signal reflects
the combined presence of the activated form of each
ERM family member, but in proportions that are as yet
unknown. To begin interrogating the influence of lipid
rafts on potential interactions between CD44 and radixin
or moesin, a siRNA approach was used. Flotillin-1 or
caveolin-1 (the two main structural proteins in lipid rafts)
were separately knocked down in MDA-MB-231 cells,
whereupon we checked for colocalization between CD44
and either moesin (Figure 2D, top panel; see also Sup-
plemental Figure S5 at http://ajp.amjpathol.org) or radixin(Figure 2D, bottom panel; see also Supplemental Figure
S5 at http://ajp.amjpathol.org). Interestingly, flotillin-1
knockdown significantly decreased CD44 and moesin
colocalization under nonmigrating conditions relative to a
siRNA negative (siRNA-ve) control. Conversely, flotillin-1
knockdown significantly increased CD44 and radixin co-
localization under nonmigrating conditions compared to
a siRNA negative control. This further supports that both
moesin and radixin could contribute to the p-ERM signal
coprecipitating with CD44 under nonmigrating conditions
(Figure 2C). It is also interesting to note that only flotillin-1
loss significantly affected the colocalization of CD44 with
either moesin or radixin, suggesting a lack of involvement
of caveolin-positive rafts in the process. However, de-
creased colocalization of CD44 with moesin was accom-
panied by decreased expression of the latter in flotillin-1
knockdown cells (see Supplemental Figure S5 at http://
ajp.amjpathol.org).
CD44 and Ezrin Binding Is Sensitive to Raft
Disruption or Altered CD44 Raft Affiliation
To further probe the proposed interaction of CD44 and
ezrin outside lipid raft domains in migrating MDA-MB-231
breast cancer cells, we tested the effect of pharmacolog-
ical disruption of lipid rafts on CD44-ezrin interactions.
Confluent cells were treated with the cholesterol-seques-
tering reagent MCD (10 mmol/L) to disrupt lipid rafts,
and then allowed to migrate in serum-free medium and
immunoprecipitated for CD44. CD44 recovery was mar-
ginally increased in MCD-treated cells compared to
controls. However, there was a large increase in ezrin
recovery in CD44 immunoprecipitates from raft-disrupted
(MCD-treated) cells (Figure 3A). Western blot quantifi-
cation analysis revealed the increase in ezrin binding to
CD44 MCD-treated cells versus controls was statisti-
cally significant (Figure 3A) (P  0.0412). No significant
alteration in p-ERM-CD44 coprecipitation was observed
between control and MCD-treated cells when each was
normalized to their respective levels of total ezrin de-
tected in CD44 immunoprecipitates (Figure 3A). Further-
more, CD44 levels in the input lysates were confirmed to
be similar between treatment conditions (Figure 3A), and
neither CD44 nor ezrin were recovered from negative
control experiments using nonspecific IgG as the immu-
noprecipitating antibody.
Because interference with the raft structure affected
interactions between CD44 and ezrin, we next tested the
effect of raft disruption on cell migration. Confluent MDA-
MB-231 cells exposed to MCD or vehicle were scratch
wounded and their migration quantitated over time. How-
ever, MCD-treated cells in fact migrated slower than
untreated cells, with the two slopes showing statistically
significant differences (Figure 3B, P  0.0144). This poten-
tial conflict was explained by immunofluorescence analysis
(Figure 3C), in whichMCD-treated cells showed increased
CD44 and ezrin colocalization throughout the cell mem-
brane rather than specifically at the migrating edge where
the interaction could drive migration (Figure 3C). We hy-
pothesized that the net antimigratory effect of MCD may
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raft–mediated events.
Because the reversible posttranslational addition of
palmitoyl lipid groups has been shown to promote CD44
localization within rafts,32 we next tested whether phar-
macological inhibition of depalmitoylation would promote
CD44 retention within rafts and consequently decrease
CD44-ezrin interactions. MDA-MB-231 cells were co-
treated with two DPI, methyl arachidonyl fluorophospho-
nate and palmityl trifluoromethyl ketone, and allowed to
migrate before analyzing recovery of raft-affiliated versus
nonraft-affiliated CD44, flotillin-1, and ezrin (Figure 4A,
left panel). As before, CD44 mainly localized in lipid raft
fractions whereas ezrin was recovered mainly from non-
raft fractions. Given the challenges in defining biochem-
ical fractions/compartments, we devised a novel arithme-
tic ratio of CD44 in raft fractions to CD44 in nonraft
fractions to better describe the movement of CD44 from
raft to nonraft compartments and vice versa. Because
traditional loading controls (such as actin) are unequally
distributed throughout sucrose density gradient prepara-
tions, we had to choose separate loading controls for raft
versus nonraft fractions. Flotillin-1 was chosen as a rep-
resentative loading control strongly enriched in raft frac-
tions, and ezrin as a marker of flotillin-low nonraft frac-
tions. Thus, by densitometric quantification of blots
exposed for identical periods of time, CD44 expression
was normalized to flotillin-1 to estimate its abundance in
lipid rafts, or to ezrin to estimate its abundance in non-
lipid raft fractions. As shown in Figure 4A, DPI treatment
induced a statistically significant increase (nearly three-
fold, P  0.05) in the proportion of raft-affiliated CD44
(described by the lipid raft/non-lipid raft ratio). DPI treat-ment did not alter the raft affiliation of CD44 under non-
migrating conditions, further supporting the possibility
that CD44 translocation outside lipid rafts is activated
only during cell migration.
Having achieved increased retention of CD44 within
lipid rafts on DPI treatment, we next tested whether bind-
ing interactions between CD44 and ezrin would conse-
quently be reduced. MDA-MB-231 cells were treated with
or without DPI for 30 minutes before induction of migra-
tion (Figure 4B). As a positive control for increased CD44
and ezrin binding, some cells were treated for 30 minutes
with 10 mmol/L MCD before the induction of migration.
Following wound induction, cells were allowed to migrate
in serum-free medium for 30 minutes and immunoprecipi-
tated for CD44. As already shown (Figure 1A), CD44 and
ezrin coprecipitation was increased in migrating cells,
whereas disruption of lipid rafts due to MCD (Figure 3A)
significantly increased this binding (P  0.028). Interest-
ingly, DPI treatment, which increased CD44 retention in
lipid rafts, virtually abolished the coprecipitation of CD44
and ezrin (Figure 4B). Densitometric quantification of
CD44 and ezrin binding, normalized to CD44 expression,
is shown in Figure 4B. This was also paralleled by a
statistically significant decrease in migration after DPI
treatment (Figure 4C) (P  0.0162).
CD44 Localizes Outside Rafts after Induction of
CD44-Specific Migration by Hyaluronic Acid
Although scratch wound–induced cell migration was ca-
pable of indirectly activating CD44-ezrin interactions, we
Figure 3. Disruption of lipid rafts alters CD44-ezrin interac-
tions and cell migratory capabilities. A: CD44 was immuno-
precipitated (IP) from equal amounts of total cellular protein
isolated from MDA-MB-231 cells treated with 10 mmol/L
MCD (or vehicle) for 30 minutes in serum-free medium
before the induction of cell migration for 30 minutes (top
panel). Following MCD treatment, CD44 and ezrin binding
was significantly increased compared to that in control un-
treated cells (middle panel). Error bars refer to SEM of three
replicate experiments (unpaired two-tailed t-test, P 
0.0412). Blots from input lysates (bottom panel) confirm
similar expression levels of CD44 in both treatment condi-
tions. B: The effect of MCD on MDA-MB-231 cell migration
was tested by scratch wound assay. Cells treated with 10
mmol/L MCD for 30 minutes showed significant impair-
ments in cell migration over time. Error bars refer to SEM of
n  5 experiments (GraphPad Prism linear regression anal-
ysis, P  0.0144). C: Immunofluorescence detection of CD44
(green) and ezrin (red) in nonmigrating cells or during cell
migration in nontreated cell (control) and in cells treated with
10 mmol/L MCD for 30 minutes (left panels). After MCD
treatment, confocal imaging in the xz plane (right panels)
revealed extensive colocalization of CD44 and ezrin through-
out the membranes of cells both at the leading and trailing
edges of migrating cell sheets (arrows).also used HA as a stimulus to directly activate CD44-
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mg/mL) was chosen on the basis of its ability to promote
cell migration in scratch-wounded MDA-MB-231 cells
(Figure 5A). Because we had previously observed re-
duced CD44 recovery from lipid rafts after nonspecific
induction of migration, we hypothesized that CD44-spe-
cific migration via HA would induce a similar effect. Con-
fluent MDA-MB-231 cells were scratch wounded or left
stationary and treated with HA for 30 minutes before
isolation of raft and nonraft fractions (Figure 5B). HA
treatment in migrating cells significantly increased the
recovery of CD44 outside lipid raft fractions, compared to
the nonmigrating HA-untreated condition (Figure 5B).
However, no significant variations were observed be-
tween nonmigrating and migrating conditions in the pres-
ence of HA treatment. No changes in ezrin, actin, and
flotillin-1 raft affiliation were observed among the different
conditions. These results support the possibility that
CD44 is released from lipid rafts during CD44-mediated
cancer cell migration.32,35
Interference with Caveolin-1 or Flotillin-1 Alone
Is Not Sufficient to Alter Cell Migration
Because HA–CD44 binding has been described to be
involved in the recycling of CD4432 and since their bind-
ing has been described to happen in lipid rafts, we have
begun to investigate the types of lipid rafts involved in this
process. However, although flotillin-1 and caveolin-1
mark two different types of lipid rafts, biochemical sepa-
ration via sucrose density gradient fractionation cannot
easily distinguish between them. In fact, caveolin-1 andflotillin-1 were enriched in similar fractions in both migrat-
ing and nonmigrating MDA-MB-231 cells (Figure 6A).
We, therefore, used immunofluorescence studies to ask
whether spatial differences in the localization of either raft
marker could shed light on the potential contribution of
each raft family to migration in MDA-MB-231 cells. Mi-
grating and nonmigrating cells were double stained for
caveolin-1 or flotillin-1, and examined by confocal mi-
croscopy at the basal and suprabasal aspects of the
cells (Figure 6B). Subtle differences in the basal and
suprabasal localization patterns of flotillin-1 and caveo-
lin-1 were observed. For clarity, we define basal pole as
the lowest point along the vertical (xz) axis, right at the
point of attachment to the matrix. This was also the point
at which we could clearly see projections (filopodia, la-
mellipodia) in the flattened cells at the leading edge of
migrating cells. The aspect was a higher point along the
xz axis above the basal pole. We made this distinction to
point out that the proteins of interest differentially localize
in different planes of the cells.
Specifically, flotillin-1 at the suprabasal aspect of the
cells was predominantly enriched in the cell membrane,
and its expression levels or distribution did not vary
significantly between nonmigrating and migrating cells
(Figure 6B). By contrast, caveolin-1 expression appeared
to increase at the suprabasal aspect of migrating relative
to nonmigrating cells, and its localization was submem-
branous in addition to membranous. At the basal pole of
MDA-MB-231 cells (the surface at which the cells dynam-
ically attach to and detach from the substratum during
migration), there was a strong enrichment of flotillin-1 in
Figure 4. Forced CD44 affiliation with lipid rafts disrupts CD44
and ezrin binding and cell migratory abilities.A:MDA-MB-231 cells
were treated with depalmitoylation inhibitors (DPI; 5 mol/L
methyl arachidonyl fluorophosphonate and 20 mol/L palmityl
trifluoromethyl ketone) or vehicle for 30 minutes, and either in-
duced to migrate or left stationary for 30 minutes in serum-free
medium. Cells were extracted for lipid raft isolation with 1% Triton
X-100 and analyzed by SDS-PAGE andWestern blotting for expres-
sion of CD44, flotillin-1 (Fl-1), and ezrin (left panel). CD44 within
lipid raft fractions was normalized to flotillin-1 expression whereas
non-raft CD44was normalized to ezrin expression, and the relative
amount of CD44 in lipid rafts was given by the LR/NR ratio (right
panel). A significant increase in CD44 localization to lipid rafts in
migrating cells was observed after DPI treatment, whereas no
changes in ezrin localization were observed after DPI treatment.
Error bars refer to SEM of duplicate experiments (unpaired two-
tailed t-test, *P 0.0331. B: Ezrin and CD44 binding was analyzed
in nonmigrating (NM) or migrating (M) MDA-MB-231 cells treated
for 30minuteswith 10mmol/LMCDor a combination of theDPIs
5 mol/L methyl arachidonyl fluorophosphonate and 20 mol/L
palmityl trifluoromethyl ketone (DPI) in serum-free medium. After
treatment, cells were immunoprecipitated (IP) for CD44 and
probed for ezrin (left panel). Band quantification is also presented
(right panel). Compared to control conditions, MCD treatment
significantly increased CD44-ezrin coprecipitation, whereas DPI
greatly decreased CD44-ezrin coprecipitation. Error bars refer to
SEM of triplicate experiments) (*P  0.028, unpaired two-tailed
t-test). C: The effect of DPI treatment on MDA-MB-231 cell migra-
tion was tested by scratch wound assay. Cells were pretreated with
a combination of 5mol/L methyl arachidonyl fluorophosphonate
and 20 mol/L palmityl trifluoromethyl ketone (DPI) or vehicle for
30 minutes and then scratch wounded. Wound closure was mea-
sured over time up to 9 hours. Error bars refer to SEM of duplicate
experiments, with multiple replicates per experiment. DPI treat-
ment significantly slowed wound closure compared to con-
trol conditions (GraphPad Prism linear regression analysis,
*P  0.0162). LR, lipid raft; NR, non-lipid raft.the plasma membrane of pseudopodial projections in
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pole did not vary dramatically between migrating and
nonmigrating cells, and was again submembranous in
addition to membranous under both conditions. Overall,
there was limited colocalization between flotillin-1 and
caveolin-1 at either the suprabasal or basal cellular as-
pects, and no significant changes in colocalization were
observed during migration (confirmed by pixel overlap
quantification of multiple experiments; data not shown).
These data support the possibility that flotillin-enriched
lipid rafts and caveolin-enriched lipid rafts define differ-
ent subtypes of rafts that could be involved in different
Figure 5. HA-stimulated migration in MDA-MB-231 cells is associated with
reductions in raft-affiliated CD44. A: After wounding, MDA-MB-231 cells
were stimulated with 5 mg/mL HA (HA) or serum-free medium alone
(HA) and allowed to migrate for up to 8 hours. Wound closure was
measured over time. HA treatment promoted wound closure approximately
twofold more than control conditions, and linear regression analysis con-
firmed a statistical difference between the two curves. Error bars refer to SEM
of triplicate experiments. (***P  0.005, GraphPad Prism linear regression
analysis). B: MDA-MB-231 cells were stimulated with 5 mg/mL HA or with
vehicle alone, and scratch wounded (migrating, M) or left stationary (non-
migrating, NM). Cells were separated into lipid raft and nonraft fractions by
ultracentrifugation on sucrose gradients and each fraction analyzed by SDS-
PAGE for CD44, ezrin, flotillin-1 (Fl-1), and actin expression (top panel).
Bottom panel: CD44 localization to lipid raft (LR) versus non-lipid raft (NR)
fractions in the different conditions, expressed as LR/NR ratio. Error bars refer
to the SEM of three experiments. There was a statistically significant reduc-
tion in CD44 recovery from rafts under HA-treated or -untreated migrating
conditions compared to HA-untreated nonmigrating conditions. *P  0.031
nonmigrating versus migrating for HA; P  0.014 nonmigrating versus
migrating for HA, unpaired two-tailed t-test.cellular processes. Accordingly, in our hands, these raftpopulations had different subcellular distributions and
different patterns of re-localization in MCD-treated cells
compared to controls (Figure 7). Specifically, MCD
treatment promoted the enrichment of flotillin-1 but not
caveolin-1 staining at the leading edge of migrating cells.
To begin testing the relative involvement of flotillin-1
and caveolin-1 in driving breast cancer cell migration, we
also transiently knocked-down the expression of each
protein using siRNA technology. After 72 hours, protein
expression of either flotillin-1 or caveolin-1 was success-
fully reduced by90% (Figure 8A). Immunofluorescence
confocal micrographs of flotillin-1 and caveolin-1 further
confirmed efficient knockdown of flotillin-1 and caveolin-1
(Figure 8B, left and right panels, respectively). Surpris-
ingly, analysis of scratch-wound assays revealed that
loss of caveolin-1 or flotillin-1 alone was not sufficient to
alter cell migration relative to that in cells transfected with
negative control siRNA (Figure 8C). This likely reflects
complexity issues relating to raft crosstalk and also raft-
mediated regulation of other proteins involved in migra-
tion (besides just CD44). This was supported by double-
knockdown experiments for flotillin-1 and caveolin-1
(Figure 8D), in which the overall migratory machinery
appears to have been affected. Accordingly, scratch-
wound assays revealed that double-knockdown cells mi-
grated significantly less than control or siRNA-ve cells
(Figure 8E, P  0.0125 control versus knockdown; P 
0.0092 siRNA-ve versus knockdown, linear regression by
GraphPad Prism).
Figure 6. Flotillin-positive lipid rafts and caveolin-positive lipid rafts have
different subcellular localizations. A: Lipid rafts were isolated from migrating
(M) or nonmigrating (NM) MDA-MB-231 cells and immunoblotted for flotil-
lin-1 (Fl-1) and caveolin-1 (Cav-1). Both flotillin-1 and caveolin-1 localized in
the same fractions harvested from sucrose density gradients. B:MDA-MB-231
cells were analyzed by immunofluorescence confocal microscopy for flotil-
lin-1 (green) and caveolin-1 (red) colocalization at either the suprabasal or
basal aspects of the cells. Flotillin-1 was strongly enriched in protrusive
structures at the basal aspect of migrating cells. Three confocal micrographs
containing three to five cells each were analyzed.
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By combining the results shown in Figures 1A and 2C
within a logical framework (see Materials and Methods),
we have been able to generate a self-consistent model
for the role of lipid rafts in regulating CD44-mediated cell
migration (Figure 9). This model illustrates the natural
biophysical order of processes and is also consistent
with the interventions of MCD, DPI, and HA (Figures 4A,
5B, and 6C). Specifically, it illustrates that CD44 is likely
to move outside of rafts to interact with threonine-phos-
phorylated (active) ERM and drive migration. The move-
ment of CD44 outside rafts, which is associated with the
cell migratory phenotype, is activated by the addition of
HA or scratch wounding, and is inhibited by DPI that
cause CD44 to be retained in rafts.
Discussion
CD44 is a highly dynamic molecule involved in many
cellular processes, both physiological and pathophysio-
logical. In particular, CD44 and its variants have been
described to be altered in many cancers, including
breast.36 However, the involvement of CD44 in breast
Figure 7. MCD treatment differentially affects caveolin-1 (Cav-1) and flo-
tillin-1 (Fl-1) localization in the cell compartment. MDA-MB-231 cells were
treated with 10 mmol/L MCD or vehicle (Control) for 30 minutes and then
induced to migrate. Cells were then analyzed by immunofluorescence con-
focal microscopy for caveolin-1 (red) and flotillin-1 (green) colocalization at
either the suprabasal or basal aspect of the cells. Three confocal micrographs
containing three to five cells each were analyzed. Following MCD treat-
ment, flotillin-1 presented a different reorganization between the suprabasal
and basal aspects while caveolin-1 was distributed relatively uniformly
throughout the cells. This may suggest differential functions of lipid rafts
identified by caveolin-1 compared to those identified by flotillin-1.cancer cell migration (an early requirement for metasta-sis) is still controversial and incompletely understood.
Because CD44 is known to localize in cholesterol- and
sphingolipid-enriched regions of the cell membrane
known as lipid rafts, our study investigated the involve-
ment of rafts in regulating CD44-dependent breast can-
cer cell migration.
Although the CD44 standard isoform (CD44s) has
been described by some as inhibitory toward cell migra-
tion,37 others have reported it to be directly involved in
breast cancer invasion and tumor progression.38,39 The
invasive and metastatic breast cell line MDA-MB-231
mainly expressed CD44 with a molecular weight corre-
sponding to that of CD44s (85 kDa), and thus was a good
model to dissect mechanisms regulating CD44s during
breast cancer cell migration. Specifically, we were inter-
ested in studying CD44 regulation of cell migration via its
interaction with the cytoskeleton through the linker protein
ezrin. Because CD44 and ezrin interactions have been
described to regulate wound healing–induced migration40
and since the migratory pathways activated during wound
repair41 involve the same signaling cascades activated dur-
ing normal42 and tumor cell migration,43 scratch-wound as-
says were used as a model to induce migration of MDA-
MB-231 cells. Although CD44 and ezrin interactions during
cell migration have been widely described,8,44 to our knowl-
edge, the role of lipid rafts in regulating their interaction
during breast cancer cell migration is incompletely under-
stood.
After inducing the migration of confluent MDA-MB-231
cells by scratch wounding, co-immunoprecipitation ex-
periments revealed a net increase in CD44 and ezrin
binding. This implied a conformational change in ezrin to
release autoinhibitory binding between its N- and C-ter-
minal domains.45 Such conformational changes of ezrin
are needed for its binding with CD44, and can be gen-
erated by interactions with lipids (PIP2) or by changes in
protein phosphorylation.46 After induction of cell migra-
tion in MDA-MB-231 cells, activation of phosphatidyl-ino-
sitol 4-phosphate 5-kinase has been reported to generate
an increase in PIP2 concentration in the internal leaflet of
the plasma membrane at the cellular migrating edge.47
Subsequent interactions between PIP2 and ezrin are then
thought to induce plasma membrane localization and
activation of ezrin.17,46 To act as a cytoskeletal linker,
ezrin has not only to acquire an open conformation but
also to be phosphorylated at threonine-567, the binding
site for F-actin. Protein kinase C (PKC), which is highly
active in MDA-MB-231 cells,48 may be responsible for
this phosphorylation. In support of these findings, we
noted a strong increase in the amount of p-ERM bound to
CD44 in migrating cells. This may reflect a combination of
p-ezrin, p-radixin, and p-moesin, because all three pro-
teins have similar sizes, are expressed in breast cancer
cells, and their phospho-forms are recognized by the
p-ERM antibody. Interestingly, we also observed co-im-
munoprecipitation between CD44 and a high molecular
weight ezrin band (100 kDa). It is intriguing to speculate
that this is a product of PKC phosphorylation.49 Confocal
microscopy studies also confirmed CD44 and ezrin co-
localization at the migrating edges of MDA-MB-231 cells,
iRNA ne
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filopodial structures51 as already reported elsewhere.
Because CD44 has been described to localize to
membrane lipid rafts, and lipid rafts have been impli-
cated in regulating cancer migration,52 we wondered
whether rafts could regulate CD44 and ezrin binding by
controlling their spatial distribution within cell mem-
branes. Lipid raft extraction from migrating and nonmi-
grating MDA-MB-231 cells revealed that CD44 mainly
localized to flotillin-high lipid raft fractions, although low
levels were also detected in flotillin-low nonraft fractions.
By contrast, ezrin mainly localized to actin-positive non-
raft fractions but was not detected in flotillin-high raft
fractions. Prag et al16 suggested that nondetection of
ezrin in lipid rafts can be due to the low sensitivity of
biochemical techniques for the detection of small quan-
tities of ezrin, particularly since rafts already have a very
low total protein content. Under our conditions, CD44 and
ezrin neither colocalized in, nor co-immunoprecipitated
from, lipid raft fractions under either nonmigrating or migrat-
ing conditions. However, a small pool of nonraft CD44 re-
covered under migrating conditions coprecipitated strongly
Figure 8. Knockdown of flotillin-1 and caveolin-1 does not alter cell migra
universal negative control siRNA (-ve) was used to transiently knock down ge
or immunofluorescence analysis. A: After 72 hours, the efficiency of transfec
and caveolin-1 alone was successfully reduced by approximately 90%. (B
confirmed by immunofluorescence confocal microscopy. C: Analysis of scrat
with the negative control siRNA) did not reveal any significant differences
caveolin-1 after 72 hours from transfection was tested by Western blot analysi
double knocked down for flotillin-1 and caveolin-1 revealed significantly les
siRNA. *P  0.0125 Control versus Fl-1Cav-1 knockdown, **P  0.0092 s
GraphPad Prism.with ezrin, particularly the threonine-phosphorylated (active)form of ERM proteins. It is likely that even a small relative
shift of CD44 from raft to nonraft fractions under migratory
conditions could permit such an occurrence, and certainly
that relative shifts are more important than the absolute
presence/absence of CD44 in either raft or nonraft fractions
exclusively.
Although the mechanism whereby CD44 is retained in
nonraft fractions following the induction of migration is as
yet unknown, it is intriguing to speculate that ezrin could
sequester CD44 within nonraft fractions after their inter-
action. Supportive evidence has been drawn from a
study in which disruption of the actin cytoskeleton by
latrunculin A was found to increase CD44 localization
within lipid rafts.11 Because CD44 interacts with actin via
linker proteins such as ezrin, this suggests that actin-
binding proteins, including ezrin, may play a major role in
the lateral mobility of CD44 outside lipid rafts. However,
our preliminary experiments showed that ezrin knock-
down did not affect CD44 colocalization with flotillin-1–
positive lipid rafts (data not shown).
All together, these findings highlight the dynamic na-
ture of binding interactions between CD44 and ezrin. It
MDA-MB-231. siRNA against flotillin-1 (Fl-1) and/or caveolin-1 (Cav-1) or a
ession in MDA-MB-231 cells for 72 hours before performing migration assays
s checked by SDS-PAGE and Western blot analysis. Expression of flotillin-1
ased expression of Fl-1 and Cav-1 following siRNA knockdown was also
d assays between knockdown conditions (relative to that in cells transfected
migration. D: The efficiency of simultaneous knockdown of flotillin-1 and
llin-1 and caveolin-1 expression. E: Analysis of scratch-wound assays of cells
gration than in untreated cells or those transfected with the negative control
gative control versus Fl-1Cav-1 knockdown, linear regression analysis bytion in
ne expr
tion wa
) Decre
ch-woun
in cell
s of floti
s cell mihas also been described that this binding can be influ-
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ylation status. MDA-MB-231 cells have been shown to
possess high levels of PKC activity,48 and in vitro studies
have shown an increased interaction between CD44 and
ezrin up to 40 minutes after PKC activation.8 At approxi-
mately 40 minutes, a second phosphorylation event on
serine-291 of CD44 reportedly generates conformational
changes that decrease CD44 and ezrin affinity.8 There-
fore, we examined CD44 and ezrin interactions after 30
minutes from induction of migration, supposedly before
CD44 and ezrin disengage (estimated at 40 minutes after
the induction of migration). Results generated using this
migration model provided novel information to suggest
that the interactions between CD44 and ezrin occur out-
side lipid rafts. Although we did not directly test CD44-
ezrin interactions at later time points, our colocalization
data and the results of Legg et al8 suggest that CD44-
ezrin interactions outside lipid rafts most likely occur dur-
ing the early stages of migration.
Our hypothesis that CD44 and ezrin interact outside
lipid raft domains was further supported by experiments
in which CD44-specific migration was directly stimulated
by exposure to its extracellular matrix ligand HA. This
stimulated a significant increase in CD44 localization out-
side lipid rafts in migrating HA-treated cells compared to
the nonmigrating HA-untreated condition. It should also
be noted that there are many different types of HA frag-
ments, and it is possible that other fragments could in-
duce a greater translocation of CD44 outside of rafts. It
has been described that HA interactions with CD44 are
necessary for HA recycling and degradation35 in tumor
cell migration.53 It is possible that CD44 detection in
nonraft fractions after induction of migration could corre-
late with CD44 internalization into membrane-enclosed
vesicles, as has already been described in association
with HA degradation. To further support this hypothesis,
we found decreased levels of CD44 in single planes of
the cell membrane at 120 minutes after induction of mi-
Figure 9. Lipid raft–mediated CD44 and ezrin interaction model. The
CD44 cell migration pathway reconstructed using immunoprecipitation
experiments and logical modeling. Horizontal arrows indicate the re-
sulting flux when transiting from a stationary to migratory cell phenotype.
Our model suggests that the transit between a stationary and migratory
state is associated with release of CD44 from lipid rafts (possibly via
depalmitoylation), whereupon nonraft CD44 can bind phosphorylated
(active) ezrin to initiate migration.gration. In fact, CD44 recycling has already been de-scribed as a necessary event in cell migration.54 Addi-
tionally, we observed that in nonmigrating HA-treated
cells, CD44 recovery outside lipid rafts was not signifi-
cantly different from that in other conditions (nonmigrat-
ing HA-treated, migrating HA-treated/-untreated). This
may suggest that HA treatment in nonmigrating condi-
tions induces changes at the molecular level intermediate
between migrating and nonmigrating phenotypes. It is
possible that, following HA stimulation in nonmigrating
conditions, CD44 can only be partially internalized be-
cause contact-inhibited cells cannot properly migrate.
This might preclude any further CD44 internalization.
Moreover, depending on the size of its particles, HA
treatment could cause CD44 clustering, thereby bringing
together lipid rafts and increasing CD44 detergent insol-
ubility.11 This intermediate phenotype may help explain
the lack of statistically significant differences between
CD44 raft/nonraft segregation in HA-treated versus -un-
treated nonmigrating cells, or in HA-treated nonmigrating
versus migrating cells. Specifically, endocytosis can be a
possible mechanism involved in CD44 recycling, and it
has been described to be inhibited by MCD treat-
ments.52 Therefore, we speculate that enhanced binding
between ezrin (total or active) and CD44 after MCD
treatment may be due to a block in the endocytotic path-
way inhibiting CD44 and ezrin from disengaging and
resulting in an increased interaction between the two.
Accordingly, immunofluorescence analysis of CD44 and
ezrin after lipid raft disruption confirmed their enhanced
localization throughout cell membranes. However, be-
cause lipid rafts carry out many important regulatory
functions, extensive raft disruption due to MCD may
also interfere with other key cellular functions, including
regulation of cell polarity. It should also be noted that
MCD, although widely accepted as a pharmacological
disrupter of lipid rafts,21–23 is nonspecific in this regard.
Therefore, our crude evidence of MCD-induced raft dis-
ruption facilitating CD44-ezrin interactions could be bet-
ter refined, should more selective and specific raft-dis-
ruptive reagents become available in the future.
To further test the potential spatial control of lipid rafts
over CD44-ezrin interactions, we have begun to explore
the possibility of pharmacologically inhibiting the depar-
ture of CD44 from rafts using protein palmitoylation inhib-
itors. CD44 has two conserved cysteine residues that can
be palmitoylated,32 a posttranslational modification that
increases its hydrophobicity and affinity for lipid raft do-
mains. In turn, lipid raft proteins, such as CD44, can be
dynamically depalmitoylated by the action of palmitoyl
protein thioesterases,55 which decrease their affinity for
lipid rafts. Moreover, phosphorylation events, such as
those described during cell migration, can induce con-
formational changes that also affect the exposure of the
palmitoylation sites and, therefore, regulate protein local-
ization to lipid rafts.56 Using a combination of DPI to
prevent depalmitoylation, we successfully inhibited the
release of a pool of CD44 from lipid rafts. The net effect of
forced detainment of CD44 within rafts was that CD44-
ezrin coprecipitation was practically abolished. This was
paralleled by reduced cell migration, supporting our hy-
pothesis that lipid rafts exert a key regulatory influence on
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tion. This finding also supports the idea that CD44 and
ezrin binding is very dynamic and that the relative spatial
localization of these two proteins can play an important
role in regulating the physiology of binding. However, DPI
represent a class of nonselective inhibitors about which
little is known, thus the observed functional effects in our
exploratory experiments cannot at this time be attributed
solely to changes in CD44 palmitoylation status. Because
CD44 localization to lipid rafts is due to CD44 palmitoyl-
ation on specific cysteines, this represents a logical fu-
ture strategy to better interrogate the specific contribution
of CD44 palmitoylation changes to the functional modu-
lation of cell migration. We speculate that phosphoryla-
tion events during cell migration may induce conforma-
tional changes in CD44 that mask its palmitoylation sites,
decreasing CD44 affinity for lipid rafts. We suggest that this
may be a possible mechanism involved in the control of
CD44-ezrin relocation outside lipid rafts during breast can-
cer cell migration. However, further studies are needed to
assess this mechanism.
Many different types of lipid rafts have been described
to play roles in cell migration. Flotillin-1 and caveolin-1
represent two key markers of different raft populations.
Our studies in MDA-MB-231 cells suggest that CD44
predominantly associates with flotillin-positive rather than
caveolin-positive rafts. Immunofluorescence analysis
also confirmed that caveolin-1 knockdown does not sig-
nificantly alter CD44 and flotillin-1 colocalization during
migration (data not shown), supporting our hypothesis
that CD44-dependent cell migration is not under direct
regulatory control by caveolin-positive lipid rafts. Accord-
ingly, recent publications describe CD44 as a carrier in
non-caveolar, clathrin-independent pathways in mouse
embryonic fibroblasts.54 Interestingly, however, transient
knockdown of neither flotillin-1 nor caveolin-1 was suffi-
cient to alter cell migratory characteristics over a short
time course in our scratch-wound migration assays rela-
tive to a negative control siRNA. Although an increase in
migration might have been expected under flotillin knock-
down conditions if CD44 was indeed being released from
rafts and becoming free to interact with ezrin, it must be
remembered that lipid rafts are highly complex structures
that regulate the location and function of many cellular
proteins. Several such proteins (including key kinases
and focal adhesion proteins, including Src and FAK) are
known to play key roles in cell migration.57 Therefore,
there are likely to be compensatory mechanisms that act
to preserve important cellular functions (such as migra-
tion) even in the event of raft loss. Spatial and temporal
considerations must also be taken into account, because
stable loss of caveolin-1 has been reported to reduce
invasive behavior in breast cancer cells over a longer
timescale.58 Accordingly, long-term loss of caveolin-1
has been described to be associated with cell transfor-
mation and tumoral growth.59 Furthermore, potential
crosstalk between flotillin-1 and caveolin-1 may also im-
pact cell functional behavior. For example, in intestinal
epithelial cells, flotillin-1 down-regulation has been re-
ported to down-regulate caveolin-1 availability by pre-
venting its lysosomal degradation.60 In fact, scratch-wound assays revealed that cells doubly knocked down
for flotillin-1 and caveolin-1 migrated significantly less
than control or siRNA negative control cells, further sup-
porting the hypothesis that an organized lipid raft ma-
chinery is needed to allow functional cell migration. We
speculate that the complete loss of rafts may inflict a
global dysregulation on cell migration via the uncoupling
of various signaling pathways that depend on raft/nonraft
segregation of effector components. Overall, our studies
highlight that the regulation of CD44-dependent cell mi-
gration by either flotillin-positive or caveolin-positive lipid
rafts is complex, and will require very specific experimen-
tal approaches in the future to dissect the relative roles of
each type of raft population (as well as their crosstalk).
Taken together, our observations have shed novel light
on the role of lipid rafts in regulating CD44-mediated cell
migration. It is interesting to note that our surface area
calculations estimated only10% of cells to be migrating
at any one time, despite our extensive scratch-wounding
protocol. This calculation is only a crude physical approx-
imation of the number of migrating cells at 30 minutes
after stimulation. On the basis of immunofluorescent ob-
servations of flattened cells, we estimated that four to five
cells back from each wound edge were likely to be ac-
tively migrating. However, it is known that even cells
behind the migrating edge are also affected by wound-
ing. Indeed, injured epithelial cells release ATP and dif-
ferent chemotactic factors into culture medium in vitro,
thereby activating calcium waves that trigger different
early responses through activation of A disintegrin and
metalloproteases and epidermal growth factor receptors,
both of which are involved in the activation of migratory
pathways.29 This suggests that our estimate of only
10% cell migration is very conservative, and could ex-
plain why statistically significant differences in submem-
branous trafficking of CD44 and its interactions with ezrin
were detected even at such low levels of migration. Be-
cause only small numbers of cells are likely to migrate out
of a tumor during early invasion and metastasis, it is
intriguing to speculate that our mechanism is biologically
relevant to that scenario. However, in vivo experimenta-
tion would be necessary to better investigate the real
relevance to tumor metastasis. Using experimental data
to construct a logical framework based on our in vitro
data, we propose a model (Figure 9) whereby lipid rafts
regulate interactions between CD44 with ezrin in its ac-
tive (phosphorylated) form to orchestrate breast cancer
cell migration. Specifically, in the stationary state, CD44
is mostly retained within rafts and unable to interact with
phospho-ERM proteins to drive migration. On exposure
to a migratory stimulus (such as nonspecific wounding or
CD44-specific stimulation with HA), CD44 moves out of
rafts, potentially following its depalmitoylation, and is free
to interact with activated ERM proteins. This is then as-
sociated with the migratory phenotype. We speculate that
further exploration of mechanisms to specifically target
and modulate CD44 localization to lipid rafts may have
value for the long-term development of new anti-migra-
tory breast cancer treatments.
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